Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioninositol 1,4,5-trisphosphate-gated calcium channel activity

ITPR1 ITPR3

1.49e-053452GO:0005220
GeneOntologyCellularComponentplatelet dense tubular network membrane

ITPR1 ITPR3

1.62e-049452GO:0031095
GeneOntologyCellularComponentplatelet dense tubular network

ITPR1 ITPR3

2.46e-0411452GO:0031094
GeneOntologyCellularComponentmyosin complex

MYO1G MLPH MYO1H

2.79e-0459453GO:0016459
DomainInsP3_rcpt-bd

ITPR1 ITPR3

1.62e-053442IPR000493
DomainRIH_assoc

ITPR1 ITPR3

8.09e-056442PF08454
DomainRIH_assoc-dom

ITPR1 ITPR3

8.09e-056442IPR013662
DomainRIH_dom

ITPR1 ITPR3

8.09e-056442IPR000699
DomainIns145_P3_rcpt

ITPR1 ITPR3

8.09e-056442IPR014821
DomainRyanodine_recept-rel

ITPR1 ITPR3

8.09e-056442IPR015925
Domain-

ITPR1 ITPR3

8.09e-0564421.25.10.30
DomainRYDR_ITPR

ITPR1 ITPR3

8.09e-056442PF01365
DomainIns145_P3_rec

ITPR1 ITPR3

8.09e-056442PF08709
DomainMIR

ITPR1 ITPR3

2.41e-0410442PS50919
DomainMIR

ITPR1 ITPR3

2.41e-0410442PF02815
DomainMIR

ITPR1 ITPR3

2.41e-0410442SM00472
DomainMIR_motif

ITPR1 ITPR3

2.41e-0410442IPR016093
DomainEGF_CA

ADGRE5 FBLN5 NPNT

1.09e-0386443PF07645
DomainEGF_Ca-bd_CS

ADGRE5 FBLN5 NPNT

1.54e-0397443IPR018097
DomainEGF_CA

ADGRE5 FBLN5 NPNT

1.63e-0399443PS01187
DomainASX_HYDROXYL

ADGRE5 FBLN5 NPNT

1.68e-03100443PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

ADGRE5 FBLN5 NPNT

1.99e-03106443IPR000152
DomainEGF_3

ADAM29 ADGRE5 FBLN5 NPNT

2.24e-03235444PS50026
DomainEGF-like_dom

ADAM29 ADGRE5 FBLN5 NPNT

2.75e-03249444IPR000742
DomainEGF_CA

ADGRE5 FBLN5 NPNT

2.96e-03122443SM00179
DomainEGF_1

ADAM29 FBLN5 USH2A NPNT

3.00e-03255444PS00022
DomainEGF-like_Ca-bd_dom

ADGRE5 FBLN5 NPNT

3.10e-03124443IPR001881
DomainGrowth_fac_rcpt_

ADGRE5 FBLN5 NPNT

5.89e-03156443IPR009030
PathwayKEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY

ITPR1 ITPR3

4.36e-055302M49000
PathwayKEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY

ITPR1 ITPR3

6.53e-056302M47960
PathwayKEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY

ITPR1 ITPR3

1.56e-049302M47852
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY

ITPR1 ITPR3

1.95e-0410302M47661
PathwayREACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS

MUC1 MUC5AC ITPR1 ITPR3

2.09e-04140304M27484
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY

ITPR1 ITPR3

2.38e-0411302M49033
PathwayREACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION

ITPR1 ITPR3

2.38e-0411302M27466
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

3.37e-0413302M47696
PathwayKEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

3.37e-0413302M47751
PathwayKEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY

ITPR1 ITPR3

3.37e-0413302M47656
PathwayREACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS

ITPR1 ITPR3

3.37e-0413302MM14553
PathwayREACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC

MUC1 MUC5AC

5.16e-0416302M27410
PathwayREACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS

ITPR1 ITPR3

5.16e-0416302M26945
PathwayKEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM

PIK3C2A ITPR1 ITPR3

5.51e-0476303M9052
PathwayREACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS

MUC1 MUC5AC

5.84e-0417302M27412
PathwayREACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION

ITPR1 ITPR3

7.32e-0419302M27423
PathwayKEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

7.32e-0419302M47760
PathwayKEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY

ITPR1 ITPR3

7.32e-0419302M47733
PathwayKEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

8.12e-0420302M47688
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

8.97e-0421302M47689
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC1 MUC5AC

8.97e-0421302MM15706
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

9.85e-0422302M47690
PathwayKEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

9.85e-0422302M47675
PathwayREACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS

MUC1 MUC5AC

1.08e-0323302M556
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

ITPR1 ITPR3

1.08e-0323302M47676
PathwayREACTOME_EFFECTS_OF_PIP2_HYDROLYSIS

ITPR1 ITPR3

1.27e-0325302MM14511
PathwayREACTOME_DECTIN_2_FAMILY

MUC1 MUC5AC

1.38e-0326302M27483
PathwayREACTOME_EFFECTS_OF_PIP2_HYDROLYSIS

ITPR1 ITPR3

1.49e-0327302M12123
PathwayREACTOME_PLATELET_CALCIUM_HOMEOSTASIS

ITPR1 ITPR3

1.49e-0327302MM15053
PathwayREACTOME_PLATELET_CALCIUM_HOMEOSTASIS

ITPR1 ITPR3

1.60e-0328302M924
PathwayWP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY

ABCG1 RARG

1.84e-0330302MM15866
PathwayWP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS

ABCG1 PIK3C2A ITPR1

2.02e-03119303M48309
PathwayREACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX

CDC6 RPA1

2.09e-0332302MM15368
PathwayREACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION

ITPR1 ITPR3

2.09e-0332302MM14983
PathwayBIOCARTA_NUCLEARRS_PATHWAY

ABCG1 RARG

2.22e-0333302MM1448
PathwayREACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX

CDC6 RPA1

2.22e-0333302M9694
PathwayBIOCARTA_NUCLEARRS_PATHWAY

ABCG1 RARG

2.35e-0334302M16393
PathwayWP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY

ABCG1 RARG

2.49e-0335302M39488
PathwaySIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES

ITPR1 ITPR3

2.64e-0336302M1315
PathwayWP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION

ITPR1 ITPR3

2.64e-0336302M39831
PathwayREACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS

CDC6 RPA1

2.64e-0336302MM14687
PathwayREACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS

CDC6 RPA1

2.78e-0337302M11153
PathwayPID_ATR_PATHWAY

CDC6 RPA1

3.09e-0339302M46
PathwayREACTOME_DISEASES_OF_GLYCOSYLATION

GPC1 MUC1 MUC5AC

3.40e-03143303M27275
PathwayREACTOME_DAG_AND_IP3_SIGNALING

ITPR1 ITPR3

3.41e-0341302M512
PathwayWP_2Q37_COPY_NUMBER_VARIATION_SYNDROME

GPC1 KLHL30 MLPH

3.53e-03145303M45512
PathwayWP_DNA_REPLICATION

CDC6 RPA1

3.58e-0342302M39335
PathwayREACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION

ITPR1 ITPR3

3.58e-0342302M791
PathwayWP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS

ITPR1 ITPR3

3.92e-0344302M39845
PathwaySIG_CHEMOTAXIS

ITPR1 ITPR3

4.09e-0345302M5193
PathwaySIG_BCR_SIGNALING_PATHWAY

ITPR1 ITPR3

4.28e-0346302M8626
Pubmed

PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.

FBLN5 PADI2

1.71e-06246234274450
Pubmed

Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor.

ITPR1 ITPR3

1.71e-0624628663526
Pubmed

Induction of mucin and MUC5AC expression by the protease activity of Aspergillus fumigatus in airway epithelial cells.

MUC1 MUC5AC

1.71e-06246221685325
Pubmed

The Pro335 --> Leu polymorphism of type 3 inositol 1,4,5-trisphosphate receptor found in mouse inbred lines results in functional change.

ITPR1 ITPR3

1.71e-06246215890645
Pubmed

Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis.

MUC1 MUC5AC

1.71e-06246218848467
Pubmed

MUC1 contributes to goblet cell metaplasia and MUC5AC expression in response to cigarette smoke in vivo.

MUC1 MUC5AC

1.71e-06246232401676
Pubmed

Tyr-167/Trp-168 in type 1/3 inositol 1,4,5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening.

ITPR1 ITPR3

1.71e-06246220813840
Pubmed

Heteroligomers of type-I and type-III inositol trisphosphate receptors in WB rat liver epithelial cells.

ITPR1 ITPR3

1.71e-0624627559486
Pubmed

Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.

MUC1 MUC5AC

1.71e-06246221815153
Pubmed

Role of mucins in the skin during benign and malignant conditions.

MUC1 MUC5AC

1.71e-06246221146919
Pubmed

Structural studies of inositol 1,4,5-trisphosphate receptor: coupling ligand binding to channel gating.

ITPR1 ITPR3

1.71e-06246220843799
Pubmed

Glycosylation of mucins present in gastric juice: the effect of helicobacter pylori eradication treatment.

MUC1 MUC5AC

1.71e-06246220953890
Pubmed

Increased MUC1 plus a larger quantity and complex size for MUC5AC in the peripheral airway lumen of long-term tobacco smokers.

MUC1 MUC5AC

1.71e-06246232400877
Pubmed

Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 patients.

MUC1 MUC5AC

1.71e-06246232776556
Pubmed

Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues.

ITPR1 ITPR3

1.71e-0624621374893
Pubmed

Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.

MUC1 MUC5AC

1.71e-06246229408556
Pubmed

Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling.

ITPR1 ITPR3

1.71e-06246214707143
Pubmed

Type 3 Inositol 1,4,5-Trisphosphate Receptor is a Crucial Regulator of Calcium Dynamics Mediated by Endoplasmic Reticulum in HEK Cells.

ITPR1 ITPR3

5.13e-06346231979185
Pubmed

Evidence that type I, II, and III inositol 1,4,5-trisphosphate receptors can occur as integral plasma membrane proteins.

ITPR1 ITPR3

5.13e-06346210874040
Pubmed

Expression of inositol 1,4,5-trisphosphate receptors in mouse oocytes and early embryos: the type I isoform is upregulated in oocytes and downregulated after fertilization.

ITPR1 ITPR3

5.13e-0634629808793
Pubmed

Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly.

ITPR1 ITPR3

5.13e-06346224904548
Pubmed

Ubiquitination and proteasomal degradation of endogenous and exogenous inositol 1,4,5-trisphosphate receptors in alpha T3-1 anterior pituitary cells.

ITPR1 ITPR3

5.13e-06346212421829
Pubmed

Abnormal distribution of inositol 1,4,5-trisphosphate receptors in human muscle can be related to altered calcium signals and gene expression in Duchenne dystrophy-derived cells.

ITPR1 ITPR3

5.13e-06346220395455
Pubmed

Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.

ITPR1 ITPR3

5.13e-06346217327232
Pubmed

A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.

MUC1 MUC5AC

5.13e-06346219924550
Pubmed

Identification of KRAP-expressing cells and the functional relevance of KRAP to the subcellular localization of IP3R in the stomach and kidney.

ITPR1 ITPR3

5.13e-06346222992961
Pubmed

Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases.

ITPR1 ITPR3

5.13e-06346217437169
Pubmed

Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation.

ITPR1 ITPR3

5.13e-06346216014380
Pubmed

Type 2 and type 3 inositol 1,4,5-trisphosphate (IP3) receptors promote the differentiation of granule cell precursors in the postnatal cerebellum.

ITPR1 ITPR3

5.13e-06346218194433
Pubmed

Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast.

MUC1 MUC5AC

5.13e-06346217333267
Pubmed

Mucin expression in reactive gastropathy: an immunohistochemical analysis.

MUC1 MUC5AC

5.13e-06346217227128
Pubmed

Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.

ITPR1 ITPR3

5.13e-06346217890015
Pubmed

Decreased olfactory mucus secretion and nasal abnormality in mice lacking type 2 and type 3 IP3 receptors.

ITPR1 ITPR3

5.13e-06346218547250
Pubmed

Establishment of Patient-derived Preclinical Models for Invasive Papillary Cholangiocarcinoma.

MUC1 MUC5AC

5.13e-06346234969769
Pubmed

Differences in the expression of mucins in various forms of cystitis glandularis.

MUC1 MUC5AC

5.13e-06346217659847
Pubmed

A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.

MUC1 MUC5AC

5.13e-06346235185017
Pubmed

Inositol 1,4,5-trisphosphate receptor gene variants are related to the risk of breast cancer in a Chinese population.

ITPR1 ITPR3

5.13e-06346236350267
Pubmed

Identification of a family of calcium sensors as protein ligands of inositol trisphosphate receptor Ca(2+) release channels.

ITPR1 ITPR3

5.13e-06346212032348
Pubmed

Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis.

ITPR1 ITPR3

5.13e-06346218250332
Pubmed

IP3 receptors regulate vascular smooth muscle contractility and hypertension.

ITPR1 ITPR3

5.13e-06346227777977
Pubmed

The versatility and universality of calcium signalling.

ITPR1 ITPR3

5.13e-06346211413485
Pubmed

Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes.

ITPR1 ITPR3

5.13e-06346223983250
Pubmed

The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

MUC1 MUC5AC

5.13e-06346212652076
Pubmed

Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes.

ITPR1 ITPR3

5.13e-0634629858485
Pubmed

Using concatenated subunits to investigate the functional consequences of heterotetrameric inositol 1,4,5-trisphosphate receptors.

ITPR1 ITPR3

5.13e-06346226009177
Pubmed

Meconium ileus in cystic fibrosis is not linked to central repetitive region length variation in MUC1, MUC2, and MUC5AC.

MUC1 MUC5AC

5.13e-06346224920497
Pubmed

Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line.

ITPR1 ITPR3

5.13e-06346217581770
Pubmed

Activation of the inositol (1,4,5)-triphosphate calcium gate receptor is required for HIV-1 Gag release.

ITPR1 ITPR3

5.13e-06346220427533
Pubmed

Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction.

ITPR1 ITPR3

5.13e-06346218241669
Pubmed

Receptor-activated single channels in intact human platelets.

ITPR1 ITPR3

5.13e-0634621693919
Pubmed

Granulosa cells express three inositol 1,4,5-trisphosphate receptor isoforms: cytoplasmic and nuclear Ca2+ mobilization.

ITPR1 ITPR3

5.13e-06346219068129
Pubmed

Functional inositol 1,4,5-trisphosphate receptors assembled from concatenated homo- and heteromeric subunits.

ITPR1 ITPR3

5.13e-06346223955339
Pubmed

Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia.

ITPR1 ITPR3

1.03e-05446225215520
Pubmed

Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins.

ITPR1 ITPR3

1.03e-05446214685260
Pubmed

Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.

MUC1 MUC5AC

1.03e-05446233154304
Pubmed

Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B.

ITPR1 ITPR3

1.03e-05446221424589
Pubmed

Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.

MUC1 MUC5AC

1.03e-05446224603585
Pubmed

Gastric mucin expression in first-degree relatives of gastric cancer patients.

MUC1 MUC5AC

1.03e-05446224901817
Pubmed

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.

MUC1 MUC5AC

1.03e-05446227298226
Pubmed

Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated.

ITPR1 ITPR3

1.03e-05446222082873
Pubmed

Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.

MUC1 MUC5AC

1.03e-05446225638393
Pubmed

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).

MUC1 MUC5AC

1.03e-05446236367122
Pubmed

IP3R-mediated Ca2+ signals govern hematopoietic and cardiac divergence of Flk1+ cells via the calcineurin-NFATc3-Etv2 pathway.

ITPR1 ITPR3

1.03e-05446228419336
Pubmed

Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.

MUC1 MUC5AC

1.03e-05446222269464
Pubmed

Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.

MUC1 MUC5AC

1.03e-05446217401217
Pubmed

Alternative splice variants of hTrp4 differentially interact with the C-terminal portion of the inositol 1,4,5-trisphosphate receptors.

ITPR1 ITPR3

1.03e-05446211163362
Pubmed

IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming.

ITPR1 ITPR3

1.03e-05446235494252
Pubmed

Loss of IP3 Receptor-Mediated Ca2+ Release in Mouse B Cells Results in Abnormal B Cell Development and Function.

ITPR1 ITPR3

1.03e-05446228615414
Pubmed

Stabilization of cortical actin induces internalization of transient receptor potential 3 (Trp3)-associated caveolar Ca2+ signaling complex and loss of Ca2+ influx without disruption of Trp3-inositol trisphosphate receptor association.

ITPR1 ITPR3

1.03e-05446211524429
Pubmed

Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes.

ITPR1 ITPR3

1.03e-05446210828023
Pubmed

The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.

ITPR1 ITPR3

1.03e-05446223884412
Pubmed

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].

MUC1 MUC5AC

1.03e-05446217991319
Pubmed

Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.

MUC1 MUC5AC

1.03e-05446225298197
Pubmed

Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?

MUC1 MUC5AC

1.03e-05446220929551
Pubmed

Polymorphism of human mucin genes in chest disease: possible significance of MUC2.

MUC1 MUC5AC

1.71e-05546211062147
Pubmed

Differential expression of MUC genes in endometrial and cervical tissues and tumors.

MUC1 MUC5AC

1.71e-05546216188033
Pubmed

InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences.

ITPR1 ITPR3

1.71e-05546221568942
Pubmed

The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor.

ITPR1 ITPR3

1.71e-05546219706527
Pubmed

Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12.

MUC1 MUC5AC

1.71e-05546212135769
Pubmed

Widespread expression of inositol 1,4,5-trisphosphate receptor type 1 gene (Insp3r1) in the mouse central nervous system.

ITPR1 ITPR3

1.71e-0554628081710
Pubmed

MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.

MUC1 MUC5AC

1.71e-05546216475027
Pubmed

Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum.

ITPR1 ITPR3

1.71e-05546215613488
Pubmed

Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.

ITPR1 ITPR3

2.56e-05646223463619
Pubmed

Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release.

ITPR1 ITPR3

2.56e-05646221762810
Pubmed

IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.

ITPR1 ITPR3

2.56e-05646216844763
Pubmed

A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.

ITPR1 ITPR3

2.56e-05646220519450
Pubmed

Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.

ITPR1 ITPR3

2.56e-05646225966694
Pubmed

Myosin-I isozymes in neonatal rodent auditory and vestibular epithelia.

MYO1G MYO1H

2.56e-05646212486594
Pubmed

Genetic evidence supporting caveolae microdomain regulation of calcium entry in endothelial cells.

ITPR1 ITPR3

2.56e-05646217416589
Pubmed

Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.

ITPR1 ITPR3

3.58e-05746211860456
Pubmed

Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes.

ITPR1 ITPR3

3.58e-05746222495310
Pubmed

Apical localization of a functional TRPC3/TRPC6-Ca2+-signaling complex in polarized epithelial cells. Role in apical Ca2+ influx.

ITPR1 ITPR3

6.12e-05946215623527
Pubmed

Ca2+ signals regulate mitochondrial metabolism by stimulating CREB-mediated expression of the mitochondrial Ca2+ uniporter gene MCU.

ITPR1 ITPR3

6.12e-05946225737585
Pubmed

GINS complex protein Sld5 recruits SIK1 to activate MCM helicase during DNA replication.

FBXO22 RPA1

7.65e-051046227592030
Pubmed

Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development.

ITPR1 ITPR3

9.34e-051146227514653
Pubmed

Transcription factor foxq1 controls mucin gene expression and granule content in mouse stomach surface mucous cells.

MUC1 MUC5AC

1.12e-041246218558092
Pubmed

Evidence That ITPR2-Mediated Intracellular Calcium Release in Oligodendrocytes Regulates the Development of Carbonic Anhydrase II + Type I/II Oligodendrocytes and the Sizes of Myelin Fibers.

ITPR1 ITPR3

1.54e-041446234630045
Pubmed

Inositol 1,4,5-trisphosphate receptors are essential for the development of the second heart field.

ITPR1 ITPR3

1.54e-041446221382375
Pubmed

Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle.

ITPR1 ITPR3

1.78e-041546228578927
Pubmed

ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.

GPC1 CAD RPA1 PIK3C2A NOC2L ITPR3

2.24e-0466046632780723
CytobandEnsembl 112 genes in cytogenetic band chr2q37

GPC1 KLHL30 MLPH

1.53e-03226463chr2q37
Cytoband2q37.3

KLHL30 MLPH

2.74e-03774622q37.3
GeneFamilyInositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits

ITPR1 ITPR3

9.09e-063322297
GeneFamilyMyosins, class I

MYO1G MYO1H

8.44e-0583221097
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

PPP1R37 NOC2L ITPR1 ITPR3

2.81e-04181324694
GeneFamilyCD molecules|Mucins

MUC1 MUC5AC

6.24e-0421322648
ToppCellParenchymal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GPC1 JKAMP PADI2 MYO1H ANO8

1.86e-0619846524bc53bd8ef8f4f2f4fc377aeee75126ad5d311f
ToppCellfacs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 MUC1 PADI2 KLHL30

2.18e-05159464796e63f6052189106359a4e01eae3e466bf1d593
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9

ADGRE5 CDC6 MUC1 ITPR3

2.18e-05159464655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCellP07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

FBLN5 CPED1 MUC5AC NPNT

2.29e-05161464b19f82dd98a3064581793711bb70373f18abecd9
ToppCellPND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FBLN5 CDC6 CPED1 NPNT

3.25e-05176464cb8fd56a4f935cdda19d7ab43382cdda7c307667
ToppCellClub_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

SLCO1B7 MUC1 CX3CL1 MUC5AC

3.39e-05178464be64d4be23fb96a4cdd7980c58880fdfe817747f
ToppCellRA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper

ADGRE5 CPED1 NPNT ITPR1

3.78e-05183464818fd886e0188091310825f9145fa53328f2c979
ToppCell356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells)

CDC6 MUC1 NPNT ITPR3

4.03e-05186464189b75aa98903f1cb65b624524ba6c30df7e42ff
ToppCell356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells)

CDC6 MUC1 NPNT ITPR3

4.03e-05186464261891d0b148e285339ae0b9e36136ceabd9b6f5
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.11e-051874647c44cec1c26ca5907a495f2d7e633410e2e9728f
ToppCellLA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper

ADGRE5 CPED1 NPNT ITPR1

4.20e-0518846434e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass

GPC1 FBLN5 CPED1 NPNT

4.29e-05189464dc5164591dea45b420798b94dda211be03daa70c
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

GPC1 FBLN5 CPED1 NPNT

4.38e-051904641196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.47e-051914646cb2c107bc674aa173b4009f320a1687a76f3979
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBLN5 MUC1 MLPH NPNT

4.47e-05191464f00d6824bd138b192a996e9f7de57b235bb24c18
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.65e-051934648646e573f2d2ff175f3d02bfdf214e65f3b614d3
ToppCellPND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass

GPC1 FBLN5 CPED1 NPNT

4.75e-0519446468bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.84e-051954643e24570def013d5b0b1ef1d7a5ced7dfd922590b
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.84e-051954646617abca0009ad3d8731f515f91ab275f9ea4c40
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.84e-05195464fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4
ToppCell3'-Parenchyma_lung-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.84e-05195464eec187c087e432417bc346c5d3ead72f58bf3215
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.94e-05196464b1abecc0aafc09ca70a5fde624f2a998c4aa3341
ToppCellcellseq-Epithelial-Epithelial_Alveolar|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC1 MLPH NPNT ITPR3

4.94e-05196464a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

4.94e-051964647e5addaa844e66f8160e05858c341866a80aed23
ToppCellASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq

MUC1 MLPH NPNT ITPR3

4.94e-05196464754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

APBB2 ADGRE5 FBLN5 CPED1

4.94e-051964642b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCellControl_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type

MUC1 PADI2 MLPH NPNT

5.04e-0519746444a59dfb889577b3160a5b13ada1276771a00241
ToppCellsaliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPC1 MUC5AC MLPH NPNT

5.04e-05197464d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

APBB2 ADGRE5 FBLN5 CPED1

5.04e-0519746480e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

5.04e-05197464bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCelldroplet-Mammary_Gland-nan-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RALGDS MUC1 CX3CL1 MLPH

5.04e-05197464ed3a37f532741764060d297a560eeeeec279d9c4
ToppCellsaliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

GPC1 MUC5AC MLPH NPNT

5.04e-0519746480b05c8ad9c1edc5dea3236079372475431343fe
ToppCellBiopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

MUC1 MLPH NPNT ITPR3

5.24e-051994645323d49d3be980605b3e609b7f03bddba6e50e8a
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MLPH NPNT ITPR3

5.24e-051994642dc33804f6691d7c9682e6c9b885e945fb97fc36
ToppCellEpithelial_cells|World / lung cells shred on cell class, cell subclass, sample id

MUC1 MLPH NPNT ITPR3

5.24e-05199464bbe69e44b7970f57628365ae771790f2b13d0cae
ToppCellBiopsy_IPF-Epithelial-AT2|Biopsy_IPF / Sample group, Lineage and Cell type

MUC1 MLPH NPNT ITPR3

5.24e-05199464c841d475703d3489161fb7904526bd7563d5fb0f
ToppCellBronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MUC1 MLPH NPNT ITPR3

5.34e-05200464b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCellParenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

MUC1 MLPH NPNT ITPR3

5.34e-0520046435c05cae30cd6b323d2662f1396ddeab08bc75fc
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC1 MLPH NPNT ITPR3

5.34e-052004643c251ad03fbbdae91dfd9037880ba43adbb03807
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC1 MLPH NPNT ITPR3

5.34e-05200464c905451425d1c24773bb0ca69bcf0309b277d2f1
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC1 MLPH NPNT ITPR3

5.34e-0520046465c83a3f6ee2a10bcb5b95076696232c6373a7b4
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC1 MLPH NPNT ITPR3

5.34e-0520046440e969883bc302e8fbc6b6ab9814529dc1472902
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MUC1 MLPH NPNT ITPR3

5.34e-05200464eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCellParenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

MUC1 MLPH NPNT ITPR3

5.34e-05200464ad9cdc82a647d379abc713a56db0e11bb6494106
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

MUC1 MLPH NPNT ITPR3

5.34e-05200464acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCellParenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

MUC1 MLPH NPNT ITPR3

5.34e-05200464ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCellEpithelial-B_(AT1-AT2-progenitors)|World / shred on cell class and cell subclass (v4)

MUC1 MLPH NPNT

4.59e-041464634511916904c1fac252cb68e871b782207f8137b3
ToppCelllung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass

MUC1 MLPH NPNT

4.68e-041474638a3039de45b8087f8319e2e37329acf7278219b7
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

APBB2 ZNF718 MYO1H

4.77e-0414846310dcbdb47cac908648d9d652c8095b536db19b8a
ToppCellInt-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type

LRRC63 FBLN5 CDC6

5.16e-0415246352d6f9cf1f4637c922f582705d625b4cbe3dc0c2
ToppCellfacs-MAT-Fat-24m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 MUC1 PADI2

5.16e-04152463fa03262e2853b7d35ef8cdbb652930abad90563c
ToppCellfacs-Lung-EPCAM-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

5.26e-041534632a94092937267cd2282452dfde3d328d763d4294
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

DIPK1C FBXO22 ZNF329

5.26e-0415346388ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MYO1G ADGRE5 ZNF718

5.26e-04153463d8773ee16c7d3e0834b9f64054d42336d6f9833b
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

DIPK1C FBXO22 ZNF329

5.26e-04153463553dff9688a1996d8f4ba16e60c683593d781389
ToppCellfacs-Lung-EPCAM-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

5.26e-04153463ad33c81fe6ac10e7c263d42541aae0d796923bad
ToppCellChildren_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

GPC1 MUC1 ITPR3

5.56e-0415646360f1ce38e34b582f589db1e0d6139282c1902b2b
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

OMA1 MUC1 NPNT

5.67e-041574639665a1375cfd8e9b8781c852686591226c0e0d9a
ToppCellfacs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

5.67e-04157463e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6
ToppCellfacs-SCAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

5.67e-04157463ad8c6eb34f5288288c4066119c17325afefbaafc
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC1 MUC5AC MYO1H

5.88e-0415946360b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCellfacs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

5.99e-04160463e4516b093003275084fc327d1597394a436754eb
ToppCelldroplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

OMA1 ABCG1 MYO1H

5.99e-04160463a494001b1f6dec33624f98fa3c24bad6988d0425
ToppCellfacs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

5.99e-041604630a507e3d59d7f744d0201a531ea84fa97a68aedb
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

OMA1 MUC1 NPNT

6.10e-041614631e17a993126e1f2a25ee7dfbb95a74ccb2a26791
ToppCellAdult-Mesenchymal-myofibroblast_cell-D175|Adult / Lineage, Cell type, age group and donor

GPC1 RARG MYO1H

6.10e-04161463048b7dc00746987a24bf870d4d278c4183eb04a2
ToppCelldroplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

6.10e-04161463cd4a736d0cec31477c6e8d3b07a04ede1559854b
ToppCelldroplet-Lung-30m-Hematologic-Lymphocytic_NK_ILC|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

6.10e-0416146328930ba576625b98cc15993d1499e9dc5edbb5a9
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FBLN5 MUC1 NPNT

6.21e-0416246334b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f
ToppCelldroplet-Lung-nan-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.21e-0416246366069146e2666d13c594bd76247893354a697c5d
ToppCelldroplet-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.21e-041624634b490989005bb03d4e7bbea01580f8548eff150f
ToppCelldroplet-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.21e-04162463e4a09bf1a51710f6c57e6e01edf8b4619459d96d
ToppCellE16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FBLN5 MUC1 NPNT

6.32e-0416346356b8668dbf06faa6866ec71f29b92907b73f074d
ToppCelldroplet-Lung-nan-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.32e-04163463801163c05f8fdacaebd0cb9b4c92741276bfa3e3
ToppCellfacs-Spleen-nan-3m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.43e-04164463a187bd5beca017ef657ef07c006e7f94ea3b911b
ToppCelldroplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

6.43e-04164463c2cd4e4b88cc1b80a9494f59d31339007ff824c1
ToppCelldroplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

6.43e-04164463d4d08353c7322f97ea07dd583b08661d635fff20
ToppCellPND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC1 MUC5AC MLPH

6.55e-04165463baff639a7046fb5cacb70f341b6d24cef3519f8e
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.55e-0416546393ed399b8c6278e5f1528c07758fb502d80a1a8b
ToppCelldroplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

GPC1 PADI2 KLHL30

6.55e-0416546388745bf7ecb0f7fc93077cea20171d40535dd56b
ToppCellPND14-Epithelial-Epithelial_Airway-Neurosecretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC1 MUC5AC MLPH

6.55e-041654636fdce8b23736409a23884ef3918638ffc067a86f
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.55e-0416546380f82aaab48791cb06fcb2d8ed7821f162742385
ToppCelldroplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 ANO8

6.55e-041654638c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296
ToppCellfacs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PADI2 KLHL30 ITPR3

6.55e-04165463ba041deb0d9c187f251493ccd4794b5f09abd5aa
ToppCellPND14-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MUC1 MUC5AC MLPH

6.55e-04165463dd4d36ff8efb89fee1fb4c48d1b8f46902119909
ToppCell343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

HOOK3 CARD14 NPNT

6.66e-04166463f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2
ToppCellfacs-Lung-nan-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R37 MYO1G RARG

6.66e-041664635c132f505dc5f699c87913f140344fc9f8e7e0f5
ToppCellfacs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RALGDS RARG PADI2

6.66e-0416646313027ae342994db4540e64eb910df1f42b160931
ToppCellfacs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RALGDS RARG PADI2

6.66e-04166463b21e45bd43f26149b9cd6e45c19241c82d54fb2f
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.66e-041664633213466380becf0ee3d4d9a0776ccbb1ee4eccea
ToppCellfacs-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

GPC1 PADI2 KLHL30

6.90e-0416846374dc46738f1d0a448df6c9b8288b515d92697792
ToppCellControl|World / group, cell type (main and fine annotations)

MUC5AC MLPH NPNT

6.90e-04168463a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCellwk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

ABCG1 MUC1 MUC5AC

7.14e-04170463d6e244725b21592c6056b9c443aac090f1eae836
ToppCell367C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

APBB2 ZNF718 MYO1H

7.26e-04171463943fbca8a6ac04052a2a85aca7b21a3461cd96f7
ToppCell11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class

ABCG1 MUC5AC NPNT

7.39e-041724639d4d92e2d16dfc8a394f2641653bb97de20a2530
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

ADGRE5 MLPH DEFB127

7.51e-041734639eaec30f9a3655b53ece1b66848201a7f85bbdf5
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

APBB2 DEFB127 NPNT

7.51e-04173463b799c06a6a5754668e789f70c0c8bc1508568575
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

OMA1 MUC1 NPNT

7.64e-04174463d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ADGRE5 FBLN5 CDC6

7.76e-04175463f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCellP03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ADGRE5 CPED1 NPNT

7.76e-04175463282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
DrugNorgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A

RALGDS RARG PADI2 MUC5AC ITPR1 ITPR3

2.42e-061934663708_UP
DrugNS-398; Down 200; 10uM; PC3; HT_HG-U133A

GPC1 PPP1R37 ADAM29 FBXO22 RARG ZC3H7B

2.57e-061954666892_DN
DrugEthoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

RALGDS RARG ZC3H7B MUC1 CPED1 INO80B

2.81e-061984663764_DN
DrugL(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; HL60; HT_HG-U133A

FBXO22 ZC3H7B MUC1 PADI2 INO80B ITPR3

2.89e-061994663118_UP
DrugIsocaffeine

ITPR1 ITPR3

3.99e-062462CID000001326
Drugadenophostin B

ITPR1 ITPR3

3.99e-062462CID000656722
Drugbenzene 1,2,4-trisphosphate

ITPR1 ITPR3

3.99e-062462CID000192376
Drug5-deoxy-5-fluoro-myo-inositol

ITPR1 ITPR3

1.20e-053462CID000195110
DrugCHEBI:697555

ITPR1 ITPR3

2.39e-054462CID009578246
DrugBcp-7

RPA1 MUC1

2.39e-054462CID009589384
DrugProtoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A

APBB2 ADGRE5 CAD ZC3H7B ZNF329

3.89e-051894652800_DN
Drug17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

RALGDS ZC3H7B ZNF329 ITPR1 ITPR3

4.09e-05191465993_UP
DrugPropantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A

RARG ZC3H7B CARD14 INO80B ITPR1

4.40e-051944654798_UP
DrugFlecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A

GPC1 FBXO22 RARG ZC3H7B INO80B

4.51e-051954654318_UP
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A

ABCG1 FBXO22 RARG ZC3H7B INO80B

4.51e-051954653408_DN
DrugMethotrexate [59-05-2]; Up 200; 8.8uM; PC3; HT_HG-U133A

RARG CDC6 MUC1 INO80B ITPR3

4.62e-051964656318_UP
DrugHarmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A

RALGDS RARG PADI2 INO80B ITPR3

4.74e-051974655495_UP
DrugTiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A

GPC1 APBB2 RARG ZC3H7B PADI2

4.74e-051974657011_DN
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A

GPC1 RALGDS ADGRE5 RARG ZC3H7B

4.74e-051974653515_DN
DrugNaloxone hydrochloride [357-08-4]; Down 200; 11uM; MCF7; HT_HG-U133A

ABCG1 ZC3H7B PADI2 INO80B ITPR3

4.85e-051984651506_DN
Drug(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A

GPC1 FBXO22 MUC1 INO80B ITPR3

4.85e-051984653067_UP
DrugBethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A

GPC1 ADGRE5 RARG ZC3H7B INO80B

4.85e-051984653537_DN
DrugNabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A

GPC1 APBB2 RARG MUC5AC INO80B

4.85e-051984656327_UP
DrugFlucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A

ABCG1 MUC1 CARD14 INO80B ITPR3

4.97e-051994653073_UP
Drugpioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A

ABCG1 ZC3H7B CPED1 MUC5AC ITPR1

4.97e-051994655925_DN
Drugretinoic acid; Up 200; 1uM; PC3; HG-U133A

GPC1 PPP1R37 RARG INO80B ITPR3

4.97e-05199465447_UP
DrugFluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A

GPC1 FBXO22 CPED1 MUC5AC CARD14

4.97e-051994657234_UP
DrugAC1Q7BER

ITPR1 ITPR3

5.96e-056462CID000005702
Drug3-F-InsP3

ITPR1 ITPR3

8.33e-057462CID003035756
DrugBr2BAPTA

ITPR1 ITPR3

8.33e-057462CID003081001
Drug[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate

ITPR1 ITPR3

8.33e-057462CID009547999
Drug9 mM of H

ITPR1 ITPR3

1.11e-048462CID000130464
Drug4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid

RARG MUC5AC

1.11e-048462ctd:C064545
Drugbasic copper carbonate

ITPR1 ITPR3

1.11e-048462CID000025503
DrugNs 004

ITPR1 ITPR3

1.11e-048462CID000162750
DrugF2 g

ITPR1 ITPR3

1.11e-048462CID006857713
Drugclausenamide

ITPR1 ITPR3

1.78e-0410462CID000128412
DrugUTP-NA

CAD RPA1 CX3CL1 CARD14 ITPR1 ITPR3

1.91e-04420466CID000001181
DrugR 478

ITPR1 ITPR3

2.17e-0411462CID000084223
Drug8-amino-cADPR

ITPR1 ITPR3

2.17e-0411462CID003081323
Drug4-hydroxyretinoic acid

RARG MUC5AC

2.60e-0412462ctd:C019429
Drugstrontium

CAD ITPR1 ITPR3

3.53e-0468463CID000104798
DrugAC1NQGJV

RALGDS FBLN5 CARD14

3.53e-0468463CID005195973
DrugClenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; PC3; HT_HG-U133A

ABCG1 RARG MUC5AC ITPR1

3.67e-041684644671_UP
Druglavendustin A

APBB2 PIK3C2A ITPR1 ITPR3

3.92e-04171464CID000003894
DrugAC1L8KRN

ITPR1 ITPR3

4.12e-0415462CID000403109
DrugGvapspat amide

ITPR1 ITPR3

4.12e-0415462CID000125015
Drug(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; PC3; HT_HG-U133A

MUC1 PADI2 MUC5AC ITPR1

4.47e-041774644495_UP
Drugethosuximide

ADGRE5 ITPR1 ITPR3

4.53e-0474463CID000003291
DrugTribenoside [10310-32-4]; Up 200; 8.4uM; HL60; HT_HG-U133A

APBB2 ABCG1 MUC1 PADI2

5.17e-041844642946_UP
Drugtroglitazone; Down 200; 10uM; HL60; HT_HG-U133A

GPC1 ZC3H7B PADI2 ITPR3

5.72e-041894642692_DN
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A

APBB2 ABCG1 MUC1 PADI2

5.95e-041914642137_UP
DrugPNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A

CDC6 MUC1 INO80B ITPR3

6.06e-041924646573_UP
DrugDextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A

APBB2 RALGDS RARG ZC3H7B

6.06e-041924645401_DN
DrugMethantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A

ABCG1 ZC3H7B INO80B ITPR3

6.06e-041924646254_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; HL60; HT_HG-U133A

GPC1 APBB2 MUC1 ITPR3

6.06e-041924642703_DN
DrugNaphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A

RALGDS ABCG1 MUC5AC INO80B

6.18e-041934646604_DN
DrugIsotretinoin [4759-48-2]; Up 200; 13.4uM; PC3; HT_HG-U133A

GPC1 RALGDS MUC1 CPED1

6.18e-041934647315_UP
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

APBB2 RARG ZC3H7B INO80B

6.18e-041934644338_DN
DrugThiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A

FBXO22 RARG PADI2 INO80B

6.18e-041934647033_DN
Drug0297417-0002B [362658-29-5]; Down 200; 10uM; PC3; HT_HG-U133A

ADAM29 FBXO22 CDC6 ZC3H7B

6.30e-041944646895_DN
DrugPromethazine hydrochloride [58-33-3]; Up 200; 12.4uM; HL60; HT_HG-U133A

APBB2 CPED1 PADI2 CARD14

6.30e-041944643100_UP
DrugIodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A

PPP1R37 ADGRE5 CPED1 INO80B

6.30e-041944644848_DN
DrugSTOCK1N-35215; Down 200; 10uM; PC3; HT_HG-U133A

APBB2 RARG ZC3H7B CPED1

6.30e-041944646380_DN
DrugPyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A

RARG MUC1 PADI2 ZNF329

6.30e-041944643184_DN
Drugestradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A

APBB2 ADGRE5 ZC3H7B CPED1

6.30e-041944647000_UP
DrugClotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

ADGRE5 ABCG1 MUC1 MUC5AC

6.30e-041944643166_DN
DrugMedrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A

ABCG1 RARG CPED1 ITPR1

6.43e-041954643705_DN
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A

APBB2 RALGDS ADGRE5 PADI2

6.43e-041954643470_DN
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; PC3; HT_HG-U133A

APBB2 ZC3H7B CPED1 INO80B

6.43e-041954645744_DN
DrugTiclopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A

APBB2 ZC3H7B CARD14 ITPR1

6.43e-041954644155_DN
DrugFluvastatin sodium salt [93957-55-2]; Up 200; 9.2uM; PC3; HT_HG-U133A

APBB2 PPP1R37 RARG MUC5AC

6.43e-041954646691_UP
DrugPHA-00665752 [477575-56-7]; Down 200; 10uM; MCF7; HT_HG-U133A

RARG MUC1 INO80B ITPR3

6.43e-041954646578_DN
DrugCefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A

APBB2 RALGDS CPED1 ITPR1

6.43e-041954647394_DN
DrugDAPH; Down 200; 10uM; PC3; HG-U133A

APBB2 ZC3H7B PIK3C2A MUC1

6.43e-04195464578_DN
DrugHalofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A

ZC3H7B ZNF329 ITPR1 ITPR3

6.43e-041954647469_UP
DrugMolindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A

FBXO22 RARG MUC1 INO80B

6.43e-041954644784_DN
DrugCrotamiton [483-63-6]; Down 200; 19.6uM; HL60; HT_HG-U133A

APBB2 ZC3H7B PADI2 ZNF329

6.43e-041954643050_DN
DrugMethoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; HL60; HT_HG-U133A

APBB2 ZC3H7B PADI2 MLPH

6.55e-041964642488_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A

PPP1R37 RARG ZC3H7B INO80B

6.55e-041964644689_DN
Drug(d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A

APBB2 ADGRE5 INO80B ITPR1

6.55e-041964642818_DN
Drugradicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A

APBB2 PPP1R37 RARG INO80B

6.55e-041964645947_DN
DrugResveratrol [501-36-0]; Up 200; 17.6uM; PC3; HT_HG-U133A

ABCG1 RARG CDC6 ZC3H7B

6.55e-041964645084_UP
DrugOrphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A

APBB2 PPP1R37 RARG ITPR1

6.55e-041964642318_DN
Drugwortmannin from Penicillium funiculosum; Down 200; 0.01uM; PC3; HT_HG-U133A

APBB2 FBXO22 ZC3H7B PADI2

6.55e-041964644467_DN
DrugSulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A

GPC1 APBB2 ZNF329 ITPR1

6.55e-041964641495_UP
DrugRetrorsine [480-54-6]; Down 200; 11.4uM; PC3; HT_HG-U133A

APBB2 ABCG1 RARG INO80B

6.55e-041964646601_DN
DrugDemecarium bromide [56-94-0]; Down 200; 5.6uM; PC3; HT_HG-U133A

GPC1 RARG ZC3H7B INO80B

6.55e-041964645795_DN
Drug(+/-)-blebbistatin; Down 200; 17uM; MCF7; HT_HG-U133A_EA

RARG ZC3H7B INO80B ZNF329

6.55e-04196464837_DN
DrugCetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; MCF7; HT_HG-U133A

GPC1 ABCG1 RARG INO80B

6.55e-041964644815_DN
DrugLovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A

RALGDS FBXO22 ZC3H7B ITPR1

6.55e-041964644978_DN
DrugAntimycin A [1397-94-0]; Up 200; 7.2uM; PC3; HT_HG-U133A

GPC1 RALGDS ZC3H7B INO80B

6.55e-041964642098_UP
Drugprochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A

GPC1 APBB2 FBXO22 RARG

6.55e-041964644439_DN
DrugCefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A

APBB2 ZC3H7B PADI2 MLPH

6.68e-041974642483_DN
DrugAH23848 hemicalcium salt hydrate; Up 200; 1uM; MCF7; HT_HG-U133A

GPC1 RARG ZC3H7B PADI2

6.68e-041974646890_UP
Drugrofecoxib; Down 200; 10uM; HL60; HG-U133A

RALGDS PADI2 ITPR1 ITPR3

6.68e-04197464371_DN
DrugFlurandrenolide [1524-88-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A

GPC1 ADGRE5 FBXO22 MUC1

6.68e-041974644702_DN
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A

RALGDS ZC3H7B MUC1 CARD14

6.68e-041974643412_UP
DrugRolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A

GPC1 APBB2 PPP1R37 RALGDS

6.68e-041974646449_UP
DrugMoxonidine [75438-57-2]; Down 200; 16.6uM; PC3; HT_HG-U133A

APBB2 RALGDS RARG MUC1

6.68e-041974644084_DN
Diseasedry eye syndrome (is_implicated_in)

MUC1 MUC5AC

1.36e-054452DOID:10140 (is_implicated_in)
Diseasecommon bile duct neoplasm (is_marker_for)

MUC1 MUC5AC

6.33e-058452DOID:4608 (is_marker_for)
Diseasedry eye syndrome (is_marker_for)

MUC1 MUC5AC

1.02e-0410452DOID:10140 (is_marker_for)
Diseaseallergic rhinitis (biomarker_via_orthology)

MUC1 MUC5AC

1.02e-0410452DOID:4481 (biomarker_via_orthology)
Diseaseautosomal dominant cerebellar ataxia (implicated_via_orthology)

ITPR1 ITPR3

1.49e-0412452DOID:1441 (implicated_via_orthology)
DiseaseCharcot-Marie-Tooth disease (is_implicated_in)

FBLN5 ITPR3

1.49e-0412452DOID:10595 (is_implicated_in)
Diseaseotitis media (biomarker_via_orthology)

MUC1 MUC5AC

3.05e-0417452DOID:10754 (biomarker_via_orthology)
Diseasesphingosine 1-phosphate measurement

OMA1 ITPR1

3.43e-0418452EFO_0800185
Diseasepancreatic cancer (is_marker_for)

ADGRE5 MUC1 MUC5AC

4.98e-04101453DOID:1793 (is_marker_for)
Diseaseasthma (is_marker_for)

MUC1 CX3CL1 MUC5AC

9.46e-04126453DOID:2841 (is_marker_for)
Diseaserhinitis (is_marker_for)

CX3CL1 MUC5AC

2.26e-0346452DOID:4483 (is_marker_for)
Diseaseunipolar depression, sex interaction measurement

ADAM29 FBLN5

2.77e-0351452EFO_0003761, EFO_0008343
Diseasesystemic scleroderma (is_marker_for)

MUC1 CX3CL1

2.98e-0353452DOID:418 (is_marker_for)

Protein segments in the cluster

PeptideGeneStartEntry
YIKCNISDVQCGRIQ

ADAM29

541

Q9UKF5
VAVNNCIRQLSYCKN

APBB2

441

Q92870
NCQYGVLTKPQLQQC

CPED1

751

A4D0V7
SQGQCVYRGKVCNLV

ABCG1

291

P45844
QQNPRLCKSYGTCVN

ADGRE5

121

P48960
YQNLLNVSCCELGIK

ANKRD40CL

36

Q53H64
AIVVNCYLIGQCGQL

ANO8

816

Q9HCE9
NCIINKVTRNRCQYC

RARG

131

P13631
FLRCQNNKTNYNLVC

ITPR3

1891

Q14573
VCGRYLQQQLDAANC

KLHL30

121

Q0D2K2
NCCKVGASNYLQQVV

FBXO22

226

Q8NEZ5
ANCQYGCDVVKGQIR

NPNT

136

Q6UXI9
LRCQNNKTNYNLVCE

ITPR1

1996

Q14643
YCRNVLKGCLANQAD

GPC1

271

P35052
LAVCQCRRKNYGQLD

MUC1

1181

P15941
CCQAYNLIRKQTNLF

PIK3C2A

1316

O00443
IVNCQVYGRNALNLK

LRRC63

316

Q05C16
QASGLCYNYQIRVQC

MUC5AC

1461

P98088
TNCELKVCFQYLNRG

PADI2

331

Q9Y2J8
NNYVQGHCRKICRVN

DEFB127

26

Q9H1M4
LILGCAVNCEQKQEY

HOOK3

121

Q86VS8
CKVANYCRQVQQLLG

NOC2L

561

Q9Y3T9
YCRQVQQLLGKVQEN

NOC2L

566

Q9Y3T9
GQALCSLQCYRINLQ

INO80B

326

Q9C086
VIGAYKQACQKLNCR

PPP1R37

76

O75864
CNKKVIDQQNGLYRC

RPA1

486

P27694
QLYREKVNALQAQVC

CARD14

341

Q9BXL6
CVRLFKQEGTCYQQA

CDC6

146

Q99741
LYNQQVGDCCIIRVS

RALGDS

791

Q12967
LQQTCYNLQGGFKCI

FBLN5

301

Q9UBX5
KCGAQRVNNNLQVIC

DIPK1C

336

Q0P6D2
YQLLVNSKRQCLECG

MLPH

71

Q9BV36
CNKCLEGNFYLRQNN

USH2A

826

O75445
VQLCYANVNGSCVKI

TAAR6

11

Q96RI8
NCSCVEVIGLQNKNY

SLCO1B7

456

G3V0H7
IVNKYQGLGVNQCDR

OMA1

46

Q96E52
CKVQKGGYNRINQCL

ZNF718

121

Q3SXZ3
CNQCGRAFSQKQYLI

ZNF260

166

Q3ZCT1
VLLVLENNNNYKCCQ

TM4SF18

66

Q96CE8
NAKNCVLLGNICYNC

ZCCHC13

56

Q8WW36
KYNQIRCLCQRGAEV

CAD

186

P27708
PYGCNQCQKLFRNIA

ZNF329

426

Q86UD4
YQQNQASCGKRAIIL

CX3CL1

51

P78423
QYDLCIHAQNGRKCQ

ZC3H7B

756

Q9UGR2
RGQRTNAQKYCQPCT

JKAMP

36

Q9P055
CINYCNEKLQQLFIQ

MYO1G

411

B0I1T2
CVRNLVQKYCRGITA

MYO1H

821

Q8N1T3